Cite
HARVARD Citation
Lasolle, H. et al. (2017). Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. European journal of endocrinology. 176 (6), pp. 769-777. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lasolle, H. et al. (2017). Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas. European journal of endocrinology. 176 (6), pp. 769-777. [Online].